Science Current Events | Science News | Brightsurf.com
 

Nursing home residents at heightened risk of falling in the days following

July 18, 2011
Increased surveillance over 48-hour period may decrease falls

BOSTON-Nursing home residents taking certain antidepressant medications are at an increased risk of falling in the days following the start of a new prescription or a dose increase of their current drug, according to a new study by the Institute for Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical School.

Published online in the Journal of Gerontology: Medical Sciences, the study found that nursing home residents have a fivefold increased risk of falling within two days of a new prescription for or an increased dose of a non-SSRI (selective serotonin reuptake inhibitor) antidepressant such as bupropion or venlafaxine. The findings suggest that nursing home staff should closely monitor these residents following a prescription change to prevent potential falls.

"Our results," says lead author Sarah D. Berry, M.D., M.P.H., a scientist at the Institute for Aging Research, "identify the days following a new prescription or increased dose of a non-SSRI antidepressant as a window of time associated with a particularly high risk of falling among nursing home residents."

The risk of falls, she says, may be due to acute cognitive or motor effects that have not yet been fully investigated. Certain non-SSRIs, such as trazodone, can cause postural hypotension, a dramatic decrease in blood pressure upon standing that may contribute to falls. Other non-SSRIs, like venlafaxine, can cause sedation and coordination problems that may lead to falls.

According to some estimates, more than one-third of the country's nearly 1.6 million nursing home residents take some type of antidepressant medication. Several previous studies have implicated antidepressants, including both SSRIs, such as paroxetine and sertraline, and non-SSRIs, as a risk factor for falls, especially among older adults; however, it is unclear if the risk accrues during the duration of use or if there are acute risks associated with the initiation or change in dose of a prescription.

Both tricyclic antidepressants and SSRIs, the most commonly prescribed antidepressant medications, have been associated with up to a sixfold increased risk of falls among nursing home residents in other studies. Newer drugs, including serotonin-norepinephrine reuptake inhibitors, may also be associated with falls risk. Regardless, says Dr. Berry, "these drugs are effective at treating the symptoms of depression, and many clinicians are reluctant to withhold their use based solely on a risk for falls."

Although many studies have examined chronic antidepressant use as a risk factor for falls, few have considered the short-term effects of a change in antidepressant prescription. Dr. Berry's study, called a case-crossover study, examined 1,181 residents of a Boston-area nursing home who fell, comparing the frequency of antidepressant changes during a "hazard" period (1-7 days before a fall) with the frequency of antidepressant changes during a control period (8-14 days before a fall). Information on falls was collected using the facility's federally-mandated computerized incident reports. The risk of falls was greatest within a two-day period of a change in a non-SSRI prescription (either new or existing), while no association was found between SSRIs and falls. The risk of falls diminished each day following the prescription change.

In light of her findings, says Dr. Berry, an instructor in medicine at Harvard Medical School, "nursing home staff should keep a watchful eye on residents in the days following a non-SSRI antidepressant change to prevent falls and clinicians should avoid making changes on weekends or during times when unfamiliar staff is present."

###

The study was funded by a grant from the National Institute on Aging, the Hartford Geriatrics Health Outcomes Research Scholars Awards Program, and the Men's Associates of Hebrew SeniorLife.

Scientists at the Institute for Aging Research seek to transform the human experience of aging by conducting research that will ensure a life of health, dignity and productivity into advanced age. The Institute carries out rigorous studies that discover the mechanisms of age-related disease and disability; lead to the prevention, treatment and cure of disease; advance the standard of care for older people; and inform public decision-making.

Founded in 1903, Hebrew SeniorLife, an affiliate of Harvard Medical School, is a nonprofit, nonsectarian organization devoted to innovative research, health care, education and housing that improves the lives of seniors. For more information, please visit www.hebrewseniorlife.org.

Hebrew SeniorLife Institute for Aging Research


Related Antidepressant Current Events and Antidepressant News Articles


Antidepressants fine-tune brain reward pathway to lessen neuropathic pain
Commonly used antidepressant drugs change levels of a key signaling protein in the brain region that processes both pain and mood, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published August 24 in the Proceedings of the National Academy of Sciences (PNAS).

Public Release: 23-Aug-2015 New study indicates magnetic stimulation effective in reducing bed-wetting
Bedwetting, or nocturnal enuresis, causes distress in children and young adults, as well as for their parents or caregivers.

Smoking cessation drug not boosting number of smokers who quit
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine.

Sequestered prion protein takes the good mood away, suggests new hypothesis on depression
The discovery of antidepressant drugs in the 1950s led to the first biochemical hypothesis of depression, known as the monoamine hypothesis.

Vortioxetine in depression: No hint of added benefit
Vortioxetine (trade name: Brintellix) has been approved since December 2013 for the treatment of depression in adults, but did not become actually available before May 2015.

New study reveals both benefits and risks of antidepressants during pregnancy
Treating maternal psychiatric disorder with commonly used antidepressants is associated with a lower risk of certain pregnancy complications including preterm birth and delivery by Caesarean section, according to researchers at Columbia University's Mailman School of Public Health, Columbia University Medical Center, and the New York State Psychiatric Institute.

Diagnosis of psychiatric disorders not as important as outcomes
Nailing the diagnosis of a psychiatric disorder may not be important in prescribing effective treatment, according to Mark Zimmerman, M.D., a clinical researcher at Rhode Island Hospital. His opinion editorial was published online today in the Journal of Clinical Psychiatry.

Manipulating molecule in the brain improves stress response, new target for depression treatment
Increasing the levels of a signaling molecule found in the brain can positively alter response to stress, revealing a potential new therapeutic target for treatment of depression, UT Southwestern Medical Center researchers said.

New study suggests evidence for serotonergic dissociation between anxiety and fear
Researchers from the Institute and Department of Psychiatry, Faculty of Medicine, University of S£o Paulo, (Brazil); the Imperial College of London, (UK); the University of Western Australia (Australia) and the University of Toronto (Canada) have just published a study in the Journal of Psychopharmacology suggesting that what had been clustered as anxiety disorders is not homogenous in terms of functioning of the serotonergic system.

Warts and all: How St. John's Wort can make you sick
St John's Wort can produce the same adverse reactions as antidepressants, and serious side effects can occur when the two are taken together, according to new University of Adelaide research.
More Antidepressant Current Events and Antidepressant News Articles

The Antidepressant Solution: A Step-by-Step Guide to Safely Overcoming Antidepressant Withdrawal, Dependence, and "Addiction"

The Antidepressant Solution: A Step-by-Step Guide to Safely Overcoming Antidepressant Withdrawal, Dependence, and "Addiction"
by M.D. Joseph Glenmullen M.D. (Author)


With the FDA's warning that antidepressants may cause agitation, anxiety, hostility, and even violent or suicidal tendencies, these medications are at the forefront of national legal news. Harvard physician Joseph Glenmullen has led the charge to warn the public that antidepressants are overprescribed, underregulated, and, especially, misunderstood in their side and withdrawal effects. Now he offers a solution!

More than twenty million Americans -- including over one million teens and children -- take one of today's popular antidepressants, such as Paxil, Zoloft, or Effexor. Dr. Glenmullen recognizes the many benefits of antidepressants and prescribes them to his patients, but he is also committed to warning the public of the dangers associated with overprescription. Dr....

The Antidepressant Survival Guide: The Clinically Proven Program to Enhance the Benefits and Beat the Side Effects of Your Medication

The Antidepressant Survival Guide: The Clinically Proven Program to Enhance the Benefits and Beat the Side Effects of Your Medication
by Robert J. Hedaya (Author)


"Now patients can have the best of both worlds -- freedom from depression and freedom from side effects. Dr. Robert Hedaya offers a wealth of wisdom drawn from years of clinical experience, research, and teaching. This book is a much-needed lantern in the darkness."
-- Norman Rosenthal, M.D., author of St. John's Wort: The Herbal Way to Feeling Good

* Restore the vital vitamins, minerals, and hormones necessary to maintain good health.
* Optimize your body's metabolic system.
* Restore your ability to experience pleasure in life.

An estimated twenty-five million Americans take antidepressants to combat depression, but most continue to cope with a host of debilitating side effects that equal, and sometimes outweigh, the medication's obvious benefits. Many doctors...

The Emperor's New Drugs: Exploding the Antidepressant Myth

The Emperor's New Drugs: Exploding the Antidepressant Myth
by Irving Kirsch (Author)


Irving Kirsch has the world doubting the efficacy of antidepressants. Based on fifteen years of research, The Emperor's New Drugs makes an overwhelming case that what the medical community considered a cornerstone of psychiatric treatment is little more than a faulty consensus. But Kirsch does more than just criticize: He offers a path society can follow to stop popping pills and start proper treatment.

The Soft Landing Method for Quitting Antidepressants - How to successfully get off antidepressants the right way, first time

The Soft Landing Method for Quitting Antidepressants - How to successfully get off antidepressants the right way, first time


Completely updated for 2014 with the latest advanced in our understanding of SSRI DiscontinuationEverything you need to know to ensure you have a "soft landing" as you come off antidepressantsA guide to getting off SSRI antidepressants and starting your drug free life again, from Benjamin Kramer, best-selling author of "Brain Renovation".In this clear and concise guide, Benjamin Kramer gives you an easy to implement blueprint for coming off antidepressants such as SSRIs (Selective Serotonin Re-uptake Inhibitors) using a variety of little-known techniques and tips.With a scientifically-designed tapering plan, including the use of certain other drugs and supplements where required, you can avoid coming in for landing too hard and crashing. Done properly, you CAN have a soft landing off...

Coming of Age on Zoloft: How Antidepressants Cheered Us Up, Let Us Down, and Changed Who We Are

Coming of Age on Zoloft: How Antidepressants Cheered Us Up, Let Us Down, and Changed Who We Are
by Katherine Sharpe (Author)


A compelling and troubling exploration of a generation raised on antidepressants, and a book that combines expansive interviews with substantive research-based reporting, Coming of Age on Zoloft is a vitally important and immediately engrossing study of one of America’s most pressing and omnipresent issues: our growing reliance on prescription drugs. Katherine Sharpe, the former editor of Seed magazine’s ScienceBlogs.com, addresses the questions that millions of young men and women are struggling with. “Where does my personality end and my prescription begin?” “Do I have a disease?” “Can I get better on my own?” Combining stout scientific acumen with first-person experience gained through her own struggle with antidepressants, Sharpe leads the reader through a complex...

Taking Antidepressants: Your Comprehensive Guide to Starting, Staying On, and Safely Quitting

Taking Antidepressants: Your Comprehensive Guide to Starting, Staying On, and Safely Quitting
by Michael Banov (Author)


Antidepressants are the most commonly prescribed class of medications in this country ¬ 190 million prescriptions per year have been written since 2005. Yet, consumers have few available resources to educate them in a balanced fashion about starting and stopping antidepressants. People want to know if antidepressants are really safe, whether they are addictive, and how they may affect their personality. In this book, triple board-certified psychiatrist Dr. Michael Banov walks the reader through a personalized process to help them make the right choice about starting antidepressants, staying on antidepressants, and stopping antidepressants. He includes specific guidelines on how to safely reduce and ultimately stop taking antidepressants, if it is appropriate to do so. Readers will...

The Antidepressant Antidote: Five Steps to Get Off Antidepressants Safely and Effectively

The Antidepressant Antidote: Five Steps to Get Off Antidepressants Safely and Effectively
by Bethany Butzer Ph. D. (Author)


Do you want to get off antidepressants and move toward a more full and balanced life? Have you tried several times to get off antidepressants, only to end up right back on them? If so, this book is for you. In The Antidepressant Antidote: Five Steps to Get Off Antidepressants Safely and Effectively, Bethany Butzer, Ph.D. provides practical and proven techniques to help you get off antidepressants once and for all. This life-enhancing 5-step program will teach you: • How to get the support you need as you taper off antidepressants.
• Tips to deal with the withdrawal effects that can arise when reducing your antidepressant dose.
• Techniques to let go of stress, anxiety, sadness, and depression.
• Smart choices to move you toward the type of life you desire....

The Anti-Depressant Fact Book: What Your Doctor Won't Tell You About Prozac, Zoloft, Paxil, Celexa, and Luvox

The Anti-Depressant Fact Book: What Your Doctor Won't Tell You About Prozac, Zoloft, Paxil, Celexa, and Luvox
by Peter R. Breggin (Author)


Known as "the Ralph Nader of psychiatry," Dr. Peter Breggin has been the medical expert in countless court cases involving the use or misuse of psychoactive medications. This unusual position has given him unprecedented access to private pharmaceutical research and correspondence files, information from which informs this straight-talking guide to the most prescribed and controversial category of American drugs: antidepressants. From how these drugs work in the brain to how they treat (or don't treat) depression and obsessive-compulsive, panic, and other disorders; from the documented side and withdrawal effects to what every parent needs to know about antidepressants and teenagers, The Anti-Depressant Fact Book is up-to-the minute and easy-to-access. Hard-hitting and enlightening, every...

Medications for Anxiety & Depression - A guide to choosing the antidepressant or anti-anxiety medication that's right for you

Medications for Anxiety & Depression - A guide to choosing the antidepressant or anti-anxiety medication that's right for you


*Brand new 2015 edition with an expanded section on "off-label" and experimental options, along with a fascinating explanation of the current research into the next generation of drugs to treat anxiety and depression*

Are you confused about which antidepressant is right for you? Would you like to learn all the important information on all of the antidepressants currently available?

All medications are not created equal. Just like a carpenter, you need the right tool for the job. Don't just rely on your doctor - take a proactive role in managing your recovery.

Unfortunately, doctors tend to be incredibly busy. Sometimes they just don't have the time to get all the details they need to choose the right medication for you. This means that very often,...

This Is Not an Anti-Depressant: But it might make you happy.

This Is Not an Anti-Depressant: But it might make you happy.


THIS IS NOT AN ANTI-DEPRESSANT...But it might make you happy.
If you have been trying to believe and are failing, then take a step backwards and relax.
This is not an answer to depression.
It will help you:
Believe in believing.
Believe in the idea of producing an idea.
Believe that you can believe in yourself.
Believe in the potential of your potential.
This is about stepping back and seeing yourself from the outside in.
Allow your inner capacity to emerge.
You will be surprised by what’s on the inside.


© 2015 BrightSurf.com